A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...
Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, ...
Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to ...
Journalist Natalie Winters fires back at critics of her wardrobe during her first days as a White House correspondent, ...
Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the ...
A new study uncovers a novel mechanism through which brown fat is transformed into heat, offering protection against ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The U.S. always seems to be in competition with China—economically, technologically, militarily. But how do the two countries ...